ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Biological response modifier, BRM
Antiplatelet agent: Glycoprotein IIb/IIIa-receptor antagonist
Immunoglobulin G1, anti-(human integrin αIIbβ3) Fab fragment (human-mouse monoclonal c7E3 clone p7E3VHhCγ₁ γ1-chain), disulfide with human-mouse monoclonal c7E3 clone p7E3VκhCκ kappa-chain (WHO )
- Abciximabum (Latin)
- Abciximab (German)
- Abciximab (French)
- Abciximab (Spanish)
- Abciximab (OS: USAN, BAN)
- Abciximab (Genetical Recombination) (OS: JAN)
- c7E3 (IS)
Cardiopharm, Chile; Isu Abxis, Thailand
2care4, Norway; Centocor, Czech Republic; Eli Lilly, Argentina; Eli Lilly, Australia; Eli Lilly, Belgium; Eli Lilly, Brazil; Eli Lilly, Ireland; Eli Lilly, Mexico; Eli Lilly, Malaysia; Eli Lilly and Company, United Kingdom; Eli Lilly de Chile, Chile; Janssen, Hong Kong; Janssen, Norway; Janssen Biologics, Netherlands; Janssen-Cilag, Poland; Lilly, Spain; Lilly, Finland; Lilly, Italy; Lilly, New Zealand; Lilly, Portugal; Lilly, Taiwan; Lilly, South Africa; Lilly-Pharmaserve, Greece
Centocor, Bulgaria; Eli Lilly, Switzerland; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; Fisher Farma, Netherlands; Janssen, Iceland; Janssen Biologics, Austria; Lilly, Canada; Lilly, Germany; Lilly, Sweden; Orifarm, Netherlands
|BAN||British Approved Name|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.